InVivo Therapeutics Holdings Corp (NASDAQ:NVIV)

13.37
Delayed Data
As of May 29
 +0.06 / +0.45%
Today’s Change
1.86
Today|||52-Week Range
19.68
+153.22%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues0.000.000.00----
Depreciation And Amortization183.0K190.0K184.0K--
 
 
 
 
 
Operating ExpensesGross Income-183.0K-190.0K-184.0K--
 
 
 
 
General Expenses4.2M4.0M3.7M5.5M
 
 
 
 
 
Research And Development2.8M2.4M1.6M2.3M
 
 
 
 
 
Total Operating Expenses4.4M4.2M3.8M5.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.4M-4.2M-3.8M-5.5M
 
 
 
 
 
Extraordinary Credit1.1M3.0M----
 
 
 
Extraordinary Charge-308.0K0.00-4.5M-10.3M
 
 
 
 
Interest Expense On Debt35.0K35.0K34.0K34.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.6M-1.2M-8.4M-15.8M
 
 
 
 
 
Net Income-3.6M-1.2M-8.4M-15.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS21.8M25.4M23.5M6.2M
 
 
 
 
 
Shares To Calculate EPS Diluted21.8M25.4M23.5M6.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.16-$0.04-$0.36-$2.56
 
 
 
 
 
EPS Diluted-$0.16-$0.04-$0.36-$2.56
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account